Anomaly Verified Customer Reviews (2026)

MediRoutes is an innovative cloud-based software solution tailored for the management of Non-Emergency Medical Transportation (NEMT) fleets. This comprehensive platform boasts capabilities such as real-time dispatching, automated scheduling, billing, detailed reporting, and seamless API integrations. Specifically designed for transportation service providers, it promotes effective route planning and offers real-time visibility into fleet operations, alongside integration with payers. By minimizing passenger wait times and enhancing the operational efficiency of NEMT providers, MediRoutes ensures reliability through sophisticated scheduling algorithms. It streamlines the coordination of patient transport and collaborates with all major brokers across the United States, solidifying its position as a leader in the NEMT software landscape since its inception in 2008. Furthermore, its ongoing commitment to innovation allows MediRoutes to continually adapt to the evolving needs of the transportation industry.

RouteGenie is NEMT software running medical transportation operations at scale: 600+ fleets, 20,000+ vehicles, 46 states and two countries, approximately 50,000 trips every day. Where operators feel it: schedules rebuild automatically with native multiload, not by hand; broker trips flow in and statuses flow back across 28 live integrations including ModivCare, MTM, Veyo, Verida, SafeRide Health, Alivi, MAS and Uber Health; Medicaid billing, CMS 1500, claim scrubbing and denial management live in the same system as dispatch. Multi-site operators run every location in one instance with role-based access and a complete audit trail on every trip change. Enterprise administration comes standard: SAML2 SSO, single-tenant deployment with per-customer data isolation, SOC 2 Type 1 attestation, HIPAA-aligned controls and BAAs, open REST API. Pricing is flat per vehicle with unlimited trips and unlimited users — cost tracks fleet size, not trip volume or headcount, so total cost does not climb as volume grows. Enterprise agreements include dedicated implementation, named support and RFP support. No fleet minimum.

InvisaClaim emerges as the leading comprehensive revenue platform that utilizes AI to optimize Revenue Cycle Management by effectively managing denials, appeals, prior authorizations, and ensuring compliance with the No Surprises Act, tailored for billing companies and RCM teams. Users are equipped with the ability to either upload denial letters or access a live feed to submit 835 ERAs, empowering the AI to quickly extract key patient details, CARC/RARC codes, CPT/ICD-10 codes, amounts, and deadlines, which enables the rapid generation of customized appeal letters for over 30 payers within a single minute. The platform includes a range of modules such as a Denial Workbench, NSA/IDR for verifying eligibility and capturing QPA, Prior Authorization, Pre-Check AI, A/R aging, NPPES NPI verification, deadline notifications, and a thorough audit trail. In addition, InvisaClaim effortlessly integrates with your existing clearinghouse and EHR systems, featuring partnerships with prominent organizations like Change Healthcare/Optum for services such as ERA, eligibility verification, claim status updates, and prior authorizations, with an Availity integration currently in progress and Waystar facilitating Provider Access Requests. Moreover, collaborative efforts with EHR providers like Athenahealth are being established, alongside the rollout of a FHIR R4 layer to enhance interoperability with Epic and Cerner platforms, thus ensuring a dynamic and adaptable service. In addition to its innovative capabilities, InvisaClaim places a high priority on security, maintaining HIPAA compliance and holding a SOC2 certification, which reflects its commitment to upholding the most stringent industry standards, ultimately aiming to revolutionize the revenue cycle landscape. The ongoing enhancements and integrations underline its mission to provide unparalleled support to billing professionals and RCM teams.